How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "9534"
  ["article_id"]=>
  string(4) "9534"
  [1]=>
  string(113) "How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies"
  ["article_title"]=>
  string(113) "How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies"
  [2]=>
  string(150) "Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology i"
  ["short_description"]=>
  string(150) "Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology i"
  [3]=>
  string(158) "Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology industry."
  ["description"]=>
  string(158) "Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology industry."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(170) "https://www.outsourcing-pharma.com/Article/2024/08/13/women-in-science-umotif-s-chief-marketing-officer-elaine-maynard?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(170) "https://www.outsourcing-pharma.com/Article/2024/08/13/women-in-science-umotif-s-chief-marketing-officer-elaine-maynard?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-13 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-13 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:26:38"
  ["create_at"]=>
  string(19) "2024-08-24 15:26:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

How personal loss and hope drove Elaine Maynard’s work in clinical trials and patie

Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to t

array(40) {
  [0]=>
  string(4) "9424"
  ["article_id"]=>
  string(4) "9424"
  [1]=>
  string(80) "FDA approval of needle-free spray, a major breakthrough in anaphylaxis treatment"
  ["article_title"]=>
  string(80) "FDA approval of needle-free spray, a major breakthrough in anaphylaxis treatment"
  [2]=>
  string(150) "Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA)"
  ["short_description"]=>
  string(150) "Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA)"
  [3]=>
  string(240) "Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA) has approved neffy, a 2 mg epinephrine nasal spray developed by ARS Pharmaceuticals, Inc."
  ["description"]=>
  string(240) "Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA) has approved neffy, a 2 mg epinephrine nasal spray developed by ARS Pharmaceuticals, Inc."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(170) "https://www.outsourcing-pharma.com/Article/2024/08/13/FDA-approves-needle-free-epinephrine-nasal-spray-for-anaphylaxis?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(170) "https://www.outsourcing-pharma.com/Article/2024/08/13/FDA-approves-needle-free-epinephrine-nasal-spray-for-anaphylaxis?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-13 17:29:00"
  ["add_date"]=>
  string(19) "2024-08-13 17:29:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:40"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA approval of needle-free spray, a major breakthrough in anaphylaxis treatment

Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food

array(40) {
  [0]=>
  string(4) "9405"
  ["article_id"]=>
  string(4) "9405"
  [1]=>
  string(84) "Challenges and solutions in addressing the development void for oncology biosimilars"
  ["article_title"]=>
  string(84) "Challenges and solutions in addressing the development void for oncology biosimilars"
  [2]=>
  string(154) "<p>Europe's oncology sector remains dominant, bolstered by numerous biosimilars. Despite current growth, a decline in biosimilar development fro"
  ["short_description"]=>
  string(154) "<p>Europe's oncology sector remains dominant, bolstered by numerous biosimilars. Despite current growth, a decline in biosimilar development fro"
  [3]=>
  string(250) "<p>Europe's oncology sector remains dominant, bolstered by numerous biosimilars. Despite current growth, a decline in biosimilar development from 2025 threatens future access, requiring strategic interventions to sustain progress.</p>"
  ["description"]=>
  string(250) "<p>Europe's oncology sector remains dominant, bolstered by numerous biosimilars. Despite current growth, a decline in biosimilar development from 2025 threatens future access, requiring strategic interventions to sustain progress.</p>"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(119) "http://www.gabionline.net//reports/challenges-and-solutions-in-addressing-the-development-void-for-oncology-biosimilars"
  ["blog_url"]=>
  string(119) "http://www.gabionline.net//reports/challenges-and-solutions-in-addressing-the-development-void-for-oncology-biosimilars"
  [15]=>
  string(19) "2024-08-13 17:05:39"
  ["add_date"]=>
  string(19) "2024-08-13 17:05:39"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:34"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Challenges and solutions in addressing the development void for oncology biosimilars

<p>Europe's oncology sector remains dominant, bolstered by numerous biosimilars. Despite current growth, a dec

array(40) {
  [0]=>
  string(4) "9406"
  ["article_id"]=>
  string(4) "9406"
  [1]=>
  string(78) "Biosimilars in inflammatory bowel disease: are we ready for multiple switches "
  ["article_title"]=>
  string(78) "Biosimilars in inflammatory bowel disease: are we ready for multiple switches "
  [2]=>
  string(150) "<p>A review by Teixeira FV et al. discusses whether scientific evidence is sufficient to support multiple switches between biologicals and biosi"
  ["short_description"]=>
  string(150) "<p>A review by Teixeira FV et al. discusses whether scientific evidence is sufficient to support multiple switches between biologicals and biosi"
  [3]=>
  string(222) "<p>A review by Teixeira FV et al. discusses whether scientific evidence is sufficient to support multiple switches between biologicals and biosimilars in patients with inflammatory bowel diseases (IBD) [1].</p>"
  ["description"]=>
  string(222) "<p>A review by Teixeira FV et al. discusses whether scientific evidence is sufficient to support multiple switches between biologicals and biosimilars in patients with inflammatory bowel diseases (IBD) [1].</p>"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(124) "http://www.gabionline.net//biosimilars/research/biosimilars-in-inflammatory-bowel-disease-are-we-ready-for-multiple-switches"
  ["blog_url"]=>
  string(124) "http://www.gabionline.net//biosimilars/research/biosimilars-in-inflammatory-bowel-disease-are-we-ready-for-multiple-switches"
  [15]=>
  string(19) "2024-08-13 16:59:58"
  ["add_date"]=>
  string(19) "2024-08-13 16:59:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:34"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:34"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Biosimilars in inflammatory bowel disease: are we ready for multiple switches

<p>A review by Teixeira FV et al. discusses whether scientific evidence is sufficient to support multiple switches

array(40) {
  [0]=>
  string(4) "9400"
  ["article_id"]=>
  string(4) "9400"
  [1]=>
  string(31) "Trelleborg acquires Baron Group"
  ["article_title"]=>
  string(31) "Trelleborg acquires Baron Group"
  [2]=>
  string(141) "Trelleborg has finalised the acquisition of Baron Group, the Australian-Chinese company manufacturing advanced precision silicone components."
  ["short_description"]=>
  string(141) "Trelleborg has finalised the acquisition of Baron Group, the Australian-Chinese company manufacturing advanced precision silicone components."
  [3]=>
  string(141) "Trelleborg has finalised the acquisition of Baron Group, the Australian-Chinese company manufacturing advanced precision silicone components."
  ["description"]=>
  string(141) "Trelleborg has finalised the acquisition of Baron Group, the Australian-Chinese company manufacturing advanced precision silicone components."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(103) "https://www.medicalplasticsnews.com/news/medical-plastics-company-news/trelleborg-acquires-baron-group/"
  ["blog_url"]=>
  string(103) "https://www.medicalplasticsnews.com/news/medical-plastics-company-news/trelleborg-acquires-baron-group/"
  [15]=>
  string(19) "2024-08-13 16:30:00"
  ["add_date"]=>
  string(19) "2024-08-13 16:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Trelleborg acquires Baron Group

Trelleborg has finalised the acquisition of Baron Group, the Australian-Chinese company manufacturing advanced precision

array(40) {
  [0]=>
  string(4) "9456"
  ["article_id"]=>
  string(4) "9456"
  [1]=>
  string(63) "The impact of AI and telemedicine on behavioral health services"
  ["article_title"]=>
  string(63) "The impact of AI and telemedicine on behavioral health services"
  [2]=>
  string(159) ""Telehealth already has proven its value in increasing access to care – but paired with effective, responsible AI usage, it holds the promise of mor"
  ["short_description"]=>
  string(159) ""Telehealth already has proven its value in increasing access to care – but paired with effective, responsible AI usage, it holds the promise of mor"
  [3]=>
  string(267) ""Telehealth already has proven its value in increasing access to care – but paired with effective, responsible AI usage, it holds the promise of more efficient, effective and personalized mental health services," a telepsychiatry provider CEO says.&#nl"
  ["description"]=>
  string(267) ""Telehealth already has proven its value in increasing access to care – but paired with effective, responsible AI usage, it holds the promise of more efficient, effective and personalized mental health services," a telepsychiatry provider CEO says.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(91) "https://www.healthcareitnews.com/news/impact-ai-and-telemedicine-behavioral-health-services"
  ["blog_url"]=>
  string(91) "https://www.healthcareitnews.com/news/impact-ai-and-telemedicine-behavioral-health-services"
  [15]=>
  string(19) "2024-08-12 22:59:06"
  ["add_date"]=>
  string(19) "2024-08-12 22:59:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

The impact of AI and telemedicine on behavioral health services

"Telehealth already has proven its value in increasing access to care – but paired with effective, responsibl

array(40) {
  [0]=>
  string(4) "9457"
  ["article_id"]=>
  string(4) "9457"
  [1]=>
  string(76) "Study: Healthcare and life sciences ahead of other industries in AI adoption"
  ["article_title"]=>
  string(76) "Study: Healthcare and life sciences ahead of other industries in AI adoption"
  [2]=>
  string(152) "The 451 Research report indicates that rapid AI uptake is having business results, with  81% of AI-mature healthcare enterprises doing better in 2023"
  ["short_description"]=>
  string(152) "The 451 Research report indicates that rapid AI uptake is having business results, with  81% of AI-mature healthcare enterprises doing better in 2023"
  [3]=>
  string(173) "The 451 Research report indicates that rapid AI uptake is having business results, with  81% of AI-mature healthcare enterprises doing better in 2023, year over year.&#nl"
  ["description"]=>
  string(173) "The 451 Research report indicates that rapid AI uptake is having business results, with  81% of AI-mature healthcare enterprises doing better in 2023, year over year.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(107) "https://www.healthcareitnews.com/news/study-healthcare-and-life-sciences-ahead-other-industries-ai-adoption"
  ["blog_url"]=>
  string(107) "https://www.healthcareitnews.com/news/study-healthcare-and-life-sciences-ahead-other-industries-ai-adoption"
  [15]=>
  string(19) "2024-08-12 22:53:32"
  ["add_date"]=>
  string(19) "2024-08-12 22:53:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Study: Healthcare and life sciences ahead of other industries in AI adoption

The 451 Research report indicates that rapid AI uptake is having business results, with  81% of AI-mature healthcare 

array(40) {
  [0]=>
  string(4) "9425"
  ["article_id"]=>
  string(4) "9425"
  [1]=>
  string(95) "PLAIO raises €4.3M to revolutionize pharma supply chains with AI-driven planning platform"
  ["article_title"]=>
  string(95) "PLAIO raises €4.3M to revolutionize pharma supply chains with AI-driven planning platform"
  [2]=>
  string(152) "In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million in an oversubscribed funding ro"
  ["short_description"]=>
  string(152) "In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million in an oversubscribed funding ro"
  [3]=>
  string(275) "In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million in an oversubscribed funding round to accelerate its AI-driven sales and operations planning platform designed specifically for the pharmaceutical sector."
  ["description"]=>
  string(275) "In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million in an oversubscribed funding round to accelerate its AI-driven sales and operations planning platform designed specifically for the pharmaceutical sector."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(162) "https://www.outsourcing-pharma.com/Article/2024/08/12/plaio-secures-4.3m-to-expand-ai-pharma-planning-platform?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(162) "https://www.outsourcing-pharma.com/Article/2024/08/12/plaio-secures-4.3m-to-expand-ai-pharma-planning-platform?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-12 22:51:00"
  ["add_date"]=>
  string(19) "2024-08-12 22:51:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:40"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

PLAIO raises €4.3M to revolutionize pharma supply chains with AI-driven planning pla

In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million

array(40) {
  [0]=>
  string(4) "9458"
  ["article_id"]=>
  string(4) "9458"
  [1]=>
  string(54) "FDA seeks to advance health equity for medical devices"
  ["article_title"]=>
  string(54) "FDA seeks to advance health equity for medical devices"
  [2]=>
  string(150) "The Center for Devices and Radiological Health says a new medical device discussion paper aims to spur conversation about reducing barriers and improv"
  ["short_description"]=>
  string(150) "The Center for Devices and Radiological Health says a new medical device discussion paper aims to spur conversation about reducing barriers and improv"
  [3]=>
  string(194) "The Center for Devices and Radiological Health says a new medical device discussion paper aims to spur conversation about reducing barriers and improving outcomes across diverse populations.&#nl"
  ["description"]=>
  string(194) "The Center for Devices and Radiological Health says a new medical device discussion paper aims to spur conversation about reducing barriers and improving outcomes across diverse populations.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(85) "https://www.healthcareitnews.com/news/fda-seeks-advance-health-equity-medical-devices"
  ["blog_url"]=>
  string(85) "https://www.healthcareitnews.com/news/fda-seeks-advance-health-equity-medical-devices"
  [15]=>
  string(19) "2024-08-12 21:47:03"
  ["add_date"]=>
  string(19) "2024-08-12 21:47:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA seeks to advance health equity for medical devices

The Center for Devices and Radiological Health says a new medical device discussion paper aims to spur conversation abou

array(40) {
  [0]=>
  string(4) "9459"
  ["article_id"]=>
  string(4) "9459"
  [1]=>
  string(67) "Seoul National University Hospital latest to achieve Stage 6 INFRAM"
  ["article_title"]=>
  string(67) "Seoul National University Hospital latest to achieve Stage 6 INFRAM"
  [2]=>
  string(52) "It is now working toward its Stage 7 validation.&#nl"
  ["short_description"]=>
  string(52) "It is now working toward its Stage 7 validation.&#nl"
  [3]=>
  string(52) "It is now working toward its Stage 7 validation.&#nl"
  ["description"]=>
  string(52) "It is now working toward its Stage 7 validation.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(107) "https://www.healthcareitnews.com/news/asia/seoul-national-university-hospital-latest-achieve-stage-6-infram"
  ["blog_url"]=>
  string(107) "https://www.healthcareitnews.com/news/asia/seoul-national-university-hospital-latest-achieve-stage-6-infram"
  [15]=>
  string(19) "2024-08-12 15:02:34"
  ["add_date"]=>
  string(19) "2024-08-12 15:02:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Seoul National University Hospital latest to achieve Stage 6 INFRAM

It is now working toward its Stage 7 validation.&#nl

array(40) {
  [0]=>
  string(4) "9460"
  ["article_id"]=>
  string(4) "9460"
  [1]=>
  string(40) "Rhysida claims Bayhealth Hospital breach"
  ["article_title"]=>
  string(40) "Rhysida claims Bayhealth Hospital breach"
  [2]=>
  string(158) "The sophisticated ransomware group, aka the Cybersecurity Team, is auctioning "impressive" data if the Delaware health system does not pay the 25 Bitc"
  ["short_description"]=>
  string(158) "The sophisticated ransomware group, aka the Cybersecurity Team, is auctioning "impressive" data if the Delaware health system does not pay the 25 Bitc"
  [3]=>
  string(173) "The sophisticated ransomware group, aka the Cybersecurity Team, is auctioning "impressive" data if the Delaware health system does not pay the 25 Bitcoin ransom.&#nl"
  ["description"]=>
  string(173) "The sophisticated ransomware group, aka the Cybersecurity Team, is auctioning "impressive" data if the Delaware health system does not pay the 25 Bitcoin ransom.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(78) "https://www.healthcareitnews.com/news/rhysida-claims-bayhealth-hospital-breach"
  ["blog_url"]=>
  string(78) "https://www.healthcareitnews.com/news/rhysida-claims-bayhealth-hospital-breach"
  [15]=>
  string(19) "2024-08-10 01:03:52"
  ["add_date"]=>
  string(19) "2024-08-10 01:03:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Rhysida claims Bayhealth Hospital breach

The sophisticated ransomware group, aka the Cybersecurity Team, is auctioning "impressive" data if the Delaware 

array(40) {
  [0]=>
  string(4) "9401"
  ["article_id"]=>
  string(4) "9401"
  [1]=>
  string(39) "Editor's Letter: Protect the planet"
  ["article_title"]=>
  string(39) "Editor's Letter: Protect the planet"
  [2]=>
  string(154) "In today's healthcare industry, sustainability is becoming a top priority. Olivia Friett, editor of Medical Plastics News, discusses the challenges of"
  ["short_description"]=>
  string(154) "In today's healthcare industry, sustainability is becoming a top priority. Olivia Friett, editor of Medical Plastics News, discusses the challenges of"
  [3]=>
  string(197) "In today's healthcare industry, sustainability is becoming a top priority. Olivia Friett, editor of Medical Plastics News, discusses the challenges of trying to maintain a sustainable industry."
  ["description"]=>
  string(197) "In today's healthcare industry, sustainability is becoming a top priority. Olivia Friett, editor of Medical Plastics News, discusses the challenges of trying to maintain a sustainable industry."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(147) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-sustainability-insights/editor-s-letter-protect-the-planet/"
  ["blog_url"]=>
  string(147) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-sustainability-insights/editor-s-letter-protect-the-planet/"
  [15]=>
  string(19) "2024-08-10 00:00:00"
  ["add_date"]=>
  string(19) "2024-08-10 00:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Editor's Letter: Protect the planet

In today's healthcare industry, sustainability is becoming a top priority. Olivia Friett, editor of Medical Plastics